TGFB1 and pulmonary fibrosis: There exists strong evidence that alveolar EMT is primarily mediated by local production and activation of TGF-β1 [7, 8], however, using TGF-β1 inhibitors for the treatment of pulmonary fibrosis is little and the mechanism have not been identified.